Your browser doesn't support javascript.
loading
Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas.
Geyer, Felipe C; Li, Anqi; Papanastasiou, Anastasios D; Smith, Alison; Selenica, Pier; Burke, Kathleen A; Edelweiss, Marcia; Wen, Huei-Chi; Piscuoglio, Salvatore; Schultheis, Anne M; Martelotto, Luciano G; Pareja, Fresia; Kumar, Rahul; Brandes, Alissa; Fan, Dan; Basili, Thais; Da Cruz Paula, Arnaud; Lozada, John R; Blecua, Pedro; Muenst, Simone; Jungbluth, Achim A; Foschini, Maria P; Wen, Hannah Y; Brogi, Edi; Palazzo, Juan; Rubin, Brian P; Ng, Charlotte K Y; Norton, Larry; Varga, Zsuzsanna; Ellis, Ian O; Rakha, Emad A; Chandarlapaty, Sarat; Weigelt, Britta; Reis-Filho, Jorge S.
Afiliación
  • Geyer FC; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Li A; Hospital Israelita Albert Einstein, Instituto Israelita de Ensino e Pesquisa, São Paulo, 05652-900, Brazil.
  • Papanastasiou AD; Instituto do Cancer do Estado de São Paulo, São Paulo, 01246-000, Brazil.
  • Smith A; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Selenica P; Department of Pathology, Fudan University Shanghai Cancer Center, 200032, Shanghai, PR China.
  • Burke KA; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Edelweiss M; Department of Pathology, Patras General Hospital, 263 32, Patras, Greece.
  • Wen HC; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Piscuoglio S; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Schultheis AM; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Martelotto LG; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Pareja F; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Kumar R; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Brandes A; Institute of Pathology and Medical Genetics, University Hospital Basel, 4031, Basel, Switzerland.
  • Fan D; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Basili T; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Da Cruz Paula A; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Lozada JR; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Blecua P; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Muenst S; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Jungbluth AA; Department of Oncology, Xiangya Hospital, Central South University, 410008, Changsha, Hunan Province, PR China.
  • Foschini MP; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Wen HY; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Brogi E; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Palazzo J; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Rubin BP; Institute of Pathology and Medical Genetics, University Hospital Basel, 4031, Basel, Switzerland.
  • Ng CKY; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Norton L; Department of Biomedical and Neuromotor Sciences, University of Bologna, Section of Bellaria Hospital, 40139, Bologna, Italy.
  • Varga Z; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Ellis IO; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Rakha EA; Department of Pathology, Thomas Jefferson University Hospital, Philadelphia, PA, 19107, USA.
  • Chandarlapaty S; Department of Pathology, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, 44195, USA.
  • Weigelt B; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Reis-Filho JS; Institute of Pathology and Medical Genetics, University Hospital Basel, 4031, Basel, Switzerland.
Nat Commun ; 9(1): 1816, 2018 05 08.
Article en En | MEDLINE | ID: mdl-29739933
ABSTRACT
Adenomyoepithelioma of the breast is a rare tumor characterized by epithelial-myoepithelial differentiation, whose genetic underpinning is largely unknown. Here we show through whole-exome and targeted massively parallel sequencing analysis that whilst estrogen receptor (ER)-positive adenomyoepitheliomas display PIK3CA or AKT1 activating mutations, ER-negative adenomyoepitheliomas harbor highly recurrent codon Q61 HRAS hotspot mutations, which co-occur with PIK3CA or PIK3R1 mutations. In two- and three-dimensional cell culture models, forced expression of HRASQ61R in non-malignant ER-negative breast epithelial cells with or without a PIK3CAH1047R somatic knock-in results in transformation and the acquisition of the cardinal features of adenomyoepitheliomas, including the expression of myoepithelial markers, a reduction in E-cadherin expression, and an increase in AKT signaling. Our results demonstrate that adenomyoepitheliomas are genetically heterogeneous, and qualify mutations in HRAS, a gene whose mutations are vanishingly rare in common-type breast cancers, as likely drivers of ER-negative adenomyoepitheliomas.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Genes ras / Proteínas Proto-Oncogénicas c-akt / Adenomioepitelioma / Fosfatidilinositol 3-Quinasa Clase I / Mutación Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Genes ras / Proteínas Proto-Oncogénicas c-akt / Adenomioepitelioma / Fosfatidilinositol 3-Quinasa Clase I / Mutación Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos